Osaka, Japan

Takao Okuda


Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Sonehigashi, JP (1981 - 1982)
  • Toyonaka, JP (1983 - 1988)
  • Osaka, JP (1984 - 1992)

Company Filing History:


Years Active: 1981-1992

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Takao Okuda: Innovator in Antifungal and Antibiotic Research

Introduction

Takao Okuda is a prominent inventor based in Osaka, Japan. He has made significant contributions to the fields of antifungal and antibiotic research, holding a total of 7 patents. His innovative work has led to the development of various compounds that are useful in treating infectious diseases.

Latest Patents

Among his latest patents is a groundbreaking invention related to N-substituted triazole derivatives. This compound is characterized by its formula, which includes a phenyl group and various alkyl groups, making it effective as an antifungal agent. Another notable patent involves cephem derivatives, which are designed to prevent or treat bacterial infectious diseases. These compounds are represented by a general formula that includes hydrogen or methyl, carboxyl or esterified carboxyl, and are crucial in pharmaceutical applications.

Career Highlights

Throughout his career, Takao Okuda has worked with esteemed organizations such as Sumitomo Chemical Company and Sumitomo Pharmaceuticals. His experience in these companies has allowed him to refine his expertise in chemical research and development, contributing to his success as an inventor.

Collaborations

Takao Okuda has collaborated with notable colleagues, including Ikutaro Saji and Hirotada Yamada. These partnerships have fostered a collaborative environment that has enhanced the innovation process in their respective fields.

Conclusion

Takao Okuda's contributions to the fields of antifungal and antibiotic research are noteworthy. His innovative patents and collaborations reflect his dedication to advancing medical science. His work continues to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…